These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23615082)

  • 21. Improving prognosis of glioblastoma in the 21st century: who has benefited most?
    Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
    Cancer; 2012 Sep; 118(17):4228-34. PubMed ID: 22180310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical prognostic factors of adult supratentorial glioblastoma].
    Jiang HH; Ren XH; Cui Y; Li MX; Yang KY; Lei YF; Lin S
    Zhonghua Wai Ke Za Zhi; 2019 May; 57(5):377-382. PubMed ID: 31091594
    [No Abstract]   [Full Text] [Related]  

  • 23. A retrospective study of primary cerebellar glioblastoma multiforme in adults.
    Gopalakrishnan CV; Dhakoji A; Nair S; Menon G; Neelima R
    J Clin Neurosci; 2012 Dec; 19(12):1684-8. PubMed ID: 23084346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
    Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
    J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Colman H; Berkey BA; Maor MH; Groves MD; Schultz CJ; Vermeulen S; Nelson DF; Mehta MP; Yung WK;
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):818-24. PubMed ID: 16887285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis.
    Sonabend AM; Zacharia BE; Goldstein H; Bruce SS; Hershman D; Neugut AI; Bruce JN
    J Neurosurg; 2014 Feb; 120(2):300-8. PubMed ID: 24286142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
    Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
    Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study.
    Chang SM; Barker FG
    Cancer; 2005 Nov; 104(9):1975-84. PubMed ID: 16130137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome and prognostic features in adult pineoblastomas: analysis of cases from the SEER database.
    Selvanathan SK; Hammouche S; Smethurst W; Salminen HJ; Jenkinson MD
    Acta Neurochir (Wien); 2012 May; 154(5):863-9. PubMed ID: 22460262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
    Wen J; Chen W; Zhu Y; Zhang P
    BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional probability of long-term survival in glioblastoma: a population-based analysis.
    Johnson DR; Ma DJ; Buckner JC; Hammack JE
    Cancer; 2012 Nov; 118(22):5608-13. PubMed ID: 22569786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does 30-day readmission affect long-term outcome among glioblastoma patients?
    Nuño M; Ly D; Ortega A; Sarmiento JM; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2014 Feb; 74(2):196-204; discussion 204-5. PubMed ID: 24176955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of TP53 and RAS mutations on cerebellar glioblastomas.
    Milinkovic VP; Skender Gazibara MK; Manojlovic Gacic EM; Gazibara TM; Tanic NT
    Exp Mol Pathol; 2014 Oct; 97(2):202-7. PubMed ID: 25036404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of radiation in children with medulloblastoma/PNET.
    Santos MA; Viégas CM; Servidoni RA; Barros MH; Pinel MI; Araújo CM
    Pediatr Blood Cancer; 2007 Apr; 48(4):416-22. PubMed ID: 17034032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM).
    Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W
    Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.